tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Oncolytics provides update on study of pelareorep in gastrointestinal cancers
PremiumThe FlyOncolytics provides update on study of pelareorep in gastrointestinal cancers
1M ago
Promising Outlook for Oncolytics Biotech: Buy Rating Backed by Strong Clinical Data and Strategic Catalysts
Premium
Ratings
Promising Outlook for Oncolytics Biotech: Buy Rating Backed by Strong Clinical Data and Strategic Catalysts
1M ago
Oncolytics Biotech Reports Promising Results in Metastatic Colorectal Cancer Studies
Premium
Company Announcements
Oncolytics Biotech Reports Promising Results in Metastatic Colorectal Cancer Studies
1M ago
Oncolytics initiated with a Buy at Lake Street
PremiumThe FlyOncolytics initiated with a Buy at Lake Street
2M ago
Oncolytics Biotech’s Transformative Year: Advancements in mPDAC Treatment with Pelareorep
Premium
Ratings
Oncolytics Biotech’s Transformative Year: Advancements in mPDAC Treatment with Pelareorep
2M ago
Oncolytics Biotech’s Strategic Advances and Regulatory Prospects Bolster Buy Rating
Premium
Ratings
Oncolytics Biotech’s Strategic Advances and Regulatory Prospects Bolster Buy Rating
2M ago
Oncolytics Biotech Reports Reduced Losses in Q2 2025 Financial Update
PremiumCompany AnnouncementsOncolytics Biotech Reports Reduced Losses in Q2 2025 Financial Update
2M ago
Oncolytics Biotech Files SEC Report Incorporating Information Circular
Premium
Company Announcements
Oncolytics Biotech Files SEC Report Incorporating Information Circular
2M ago
Oncolytics reports Q2 EPS (C$0.07) vs. (C$0.10) last year
Premium
The Fly
Oncolytics reports Q2 EPS (C$0.07) vs. (C$0.10) last year
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100